Comparison between Nalbuphine and Sufentanil in suppression visceral pain and propofol induced pain during painless abortion operation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040243

Enrollment

Unknown

Registered

2020-11-26

Start date

2020-11-26

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced abortion in early pregnancy

Interventions

Sufentanil Group:Use sufentanil for analgesia

Nabulphine Group:Use nabulphine for analgesia

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Sign informed consent; 2. Aged >=18 years old; 3. ASA grade I~II; 4. Patients planning to undergo painless abortion; 5. Gestational age <14 weeks.

Exclusion criteria

Exclusion criteria: 1. Severe liver and kidney disease; 2. Previous history of vaginal delivery; 3. Abusing sedative and analgesic drugs; 4. People with mental illness; 5. People who are allergic to propofol, sufentanil and nabulphine.

Design outcomes

Primary

Measure	Time frame
Assessment of analgesic effect during operation;Postoperative analgesic effect;	—

Secondary

Measure	Time frame
Propofol-Induced Injection Pain;	—

Countries

China

Contacts

Public ContactXuesheng Liu

Department of Anesthesiology,The First Affiliated Hospital of Anhui Medical University

liuxuesheng@ahmu.edu.cn+86 18655193385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026